Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 100% of the full text of this article appears below. |
EDITOR
We agree with Plotnick and Ducharme that inhaled
anticholinergics should be added to
2 agonists for
treating acute asthma in childhood and adolescence.1 In a
follow up to our original study2 we conducted a large (434 children) prospective double blind study in children with moderate or
severe asthma treated with two doses of ipratropium
bromide.3 Briefly, we found that the rate of admission to
hospital was reduced from 52.6% to 37.5% in children with severe
asthma. Thus, 6.6 children with severe asthma (95% confidence interval
3.7 to 29.4) would need to be treated with ipratroprium to avoid one
admission to hospital. Ipratropium had no effect on the rate of
admission of children with moderate asthma. Our study therefore
strengthens the authors' conclusions regarding the use of ipratropium
bromide in acute asthma.
a Competing interests: None declared.
2 agonists for treating acute childhood and adolescent asthma? A systematic review.
BMJ
1998;
317:
971-977
2 agonists for treating acute childhood and adolescent asthma? A systematic review